Invero Pharma, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest (NCT03176186) | Invero Pharma, Inc. | 2026-03-01 |
Track Invero Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.